These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36438822)

  • 1. Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients.
    Takayama S; Namiki T; Arita R; Ono R; Kikuchi A; Ohsawa M; Saito N; Suzuki S; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T; Hisanaga A; Mitani K; Ito T
    Front Pharmacol; 2022; 13():1008946. PubMed ID: 36438822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial.
    Takayama S; Namiki T; Arita R; Ono R; Kikuchi A; Ohsawa M; Saito N; Suzuki S; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Takagi A; Yamaguchi T; Ishii T; Hisanaga A; Mitani K; Ito T
    J Infect Chemother; 2023 Nov; 29(11):1054-1060. PubMed ID: 37507087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation).
    Takayama S; Yoshino T; Koizumi S; Irie Y; Suzuki T; Fujii S; Katori R; Kainuma M; Kobayashi S; Nogami T; Yokota K; Yamazaki M; Minakawa S; Chiba S; Suda N; Nakada Y; Ishige T; Maehara H; Tanaka Y; Nagase M; Kashio A; Komatsu K; Nojiri M; Shimooki O; Nakamoto K; Arita R; Ono R; Saito N; Kikuchi A; Ohsawa M; Nakae H; Mitsuma T; Mimura M; Ishii T; Nochioka K; Chiu SW; Yamaguchi T; Namiki T; Hisanaga A; Mitani K; Ito T
    Intern Med; 2023 Jan; 62(2):187-199. PubMed ID: 36328579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of tetanus treated with Kampo medicines such as Kakkonto and Shakuyakukanzoto.
    Nakae H; Saito Y; Okuyama M; Igarashi T
    Acute Med Surg; 2017 Apr; 4(2):217-220. PubMed ID: 29123865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-superiority of Kakkonto, a Japanese herbal medicine, to a representative multiple cold medicine with respect to anti-aggravation effects on the common cold: a randomized controlled trial.
    Okabayashi S; Goto M; Kawamura T; Watanabe H; Kimura A; Uruma R; Takahashi Y; Taneichi S; Musashi M; Miyaki K
    Intern Med; 2014; 53(9):949-56. PubMed ID: 24785885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Kampo medicine Kakkonto as acute medication to treat tension-type headache among musculoskeletal pain patients using regular analgesics.
    Katsuki M; Matsumori Y; Kashiwagi K; Kawamura S; Koh A
    Rinsho Shinkeigaku; 2023 Feb; 63(2):73-77. PubMed ID: 36725011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Japanese herbal kampo medicine kakkonto with antibiotic use and surgical drainage for noninfectious mastitis: A nationwide database study.
    Endo M; Konishi T; Yamana H; Jo T; Ishikawa T; Yasunaga H
    J Obstet Gynaecol Res; 2024 Jan; 50(1):113-119. PubMed ID: 37844586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database.
    Suzuki S; Obara T; Ishikawa T; Noda A; Matsuzaki F; Arita R; Ohsawa M; Mano N; Kikuchi A; Takayama S; Ishii T
    Front Nutr; 2021; 8():762895. PubMed ID: 34869533
    [No Abstract]   [Full Text] [Related]  

  • 10. Kakkonto Inhibits Cytokine Production Induced by Rhinovirus Infection in Primary Cultures of Human Nasal Epithelial Cells.
    Saito N; Kikuchi A; Yamaya M; Deng X; Sugawara M; Takayama S; Nagatomi R; Ishii T
    Front Pharmacol; 2021; 12():687818. PubMed ID: 34531740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for daiobotanpito combined with antibiotic therapy for treatment of acute diverticulitis: a study protocol for a randomized controlled trial.
    Ogawa-Ochiai K; Yoshimura K; Shirai A; Sakai S; Moriyama H; Nakamura K; Murayama T; Ishikawa H
    Trials; 2020 Jun; 21(1):531. PubMed ID: 32546262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of kakkonto, Japanese traditional (kampo) medicine, on brain penetration of oseltamivir carboxylate in mice with reduced blood-brain barrier function.
    Ohara K; Oshima S; Fukuda N; Ochiai Y; Maruyama A; Kanamuro A; Negishi A; Honma S; Ohshima S; Akimoto M; Takenaka S; Kobayashi D
    Evid Based Complement Alternat Med; 2015; 2015():917670. PubMed ID: 25788966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Benefit Feeling Rate Based on the Sho of OTC Kakkonto, Cold Remedy and Cold Remedy with Kakkonto Combination Product.
    Okita M; Yayoshi Y; Ohara K; Negishi A; Akimoto H; Inoue N; Numajiri S; Ohshima S; Honma S; Oshima S; Kobayashi D
    Biol Pharm Bull; 2017 Oct; 40(10):1730-1738. PubMed ID: 28781292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID.
    Tokumasu K; Ueda K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Nakano Y; Hasegawa T; Otsuka Y; Obika M; Hagiya H; Kataoka H; Otsuka F
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Effects of a Kampo Medicine, Kakkonto, on Inflammatory Responses via the Suppression of Extracellular Signal-Regulated Kinase Phosphorylation in Lipopolysaccharide-Treated Human Gingival Fibroblasts.
    Kitamura H; Urano H; Ara T
    ISRN Pharmacol; 2014; 2014():784019. PubMed ID: 24693448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study.
    Ogawa-Ochiai K; Ishikawa H; Li H; Vu Quang L; Kimoto I; Takamura M; Hongawa T; Hane Y; Suzuki S; Okajima M; Mori K; Ito M; Takami A
    Front Pharmacol; 2021; 12():766402. PubMed ID: 34867392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standardization of Crude Drugs for the Japanese Pharmacopoeia].
    Hakamatsuka T
    Yakugaku Zasshi; 2020; 140(6):783-788. PubMed ID: 32475928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of pain relief effect of Goreisan for glossodynia.
    Ayuse T; Okayasu I; Tachi-Yoshida M; Sato J; Saisu H; Shimada M; Yamazaki Y; Imura H; Hosogaya N; Nakashima S
    Medicine (Baltimore); 2020 Aug; 99(33):e21536. PubMed ID: 32872000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.